Breaking

Storms along Gulf Coast may become first named storm of 2026 Atlantic hurricane season Argentina Fans Go to Extreme Lengths to Support World Cup Champions Trump's Endorsement Suffers Rare Defeat in Georgia GOP Governor Primary Supreme Court Asked to Toss Trump Administration's Attempt to Deport 330,000 Haitians Mike Collins Wins GOP Senate Primary Runoff in Georgia, Will Face Jon Ossoff US Government Aids Elon Musk's xAI in Clean Air Act Lawsuit HPE Offers Free VM Essentials Software to Compete with Broadcom's VMware Pricing Algal Bloom Turns Trump's Renovated Reflecting Pool Chartreuse Anthropic Faces Government Ban on Advanced AI Models Amidst Business Growth Amazon's Project Kuiper Faces Launch Bottlenecks Despite Satellite Readiness Storms along Gulf Coast may become first named storm of 2026 Atlantic hurricane season Argentina Fans Go to Extreme Lengths to Support World Cup Champions Trump's Endorsement Suffers Rare Defeat in Georgia GOP Governor Primary Supreme Court Asked to Toss Trump Administration's Attempt to Deport 330,000 Haitians Mike Collins Wins GOP Senate Primary Runoff in Georgia, Will Face Jon Ossoff US Government Aids Elon Musk's xAI in Clean Air Act Lawsuit HPE Offers Free VM Essentials Software to Compete with Broadcom's VMware Pricing Algal Bloom Turns Trump's Renovated Reflecting Pool Chartreuse Anthropic Faces Government Ban on Advanced AI Models Amidst Business Growth Amazon's Project Kuiper Faces Launch Bottlenecks Despite Satellite Readiness

GLP-1 receptor agonist

Steady2 stories2 sourcesLast updated: 5d ago

Related TopicsWegovy semaglutide obesity weight loss MHRA Novo Nordisk BMI NHS

Latest Stories

UK Approves Wegovy Weight-Loss Pill, Expanding Obesity Treatment Options

5d agoAI summary

UK Approves Wegovy Weight-Loss Pill, Expanding Obesity Treatment Options

The UK's MHRA has approved Wegovy, the first GLP-1 receptor agonist tablet for weight loss, making the UK the third country to authorize the pills. This expands treatment options for adults with obesity or overweight with related health conditions.

UK Approves First GLP-1 Receptor Agonist Tablet for Weight Management

5d agoAI summary

UK Approves First GLP-1 Receptor Agonist Tablet for Weight Management

The UK's MHRA has approved the first GLP-1 receptor agonist tablet, semaglutide (Wegovy), for weight loss and management. This daily pill offers a more convenient alternative to weekly injections for adults with obesity or those overweight with weight-related conditions.